#1 in Top 100 AI Companies Clutch, 2025
Accelerate innovation in Pharma and Healthcare with AI ML development services from Blackthorn AI.
With a proven track record across 100+ AI projects, our PhD-level team builds scalable, research-grade solutions for biotech innovation, healthcare analytics, fintech optimization, and energy intelligence.
All Industries
Accelerate innovation with AI solutions by Blackthorn AI, powered by our modular White-Label Suite (WLS). Automate workflows, extract insights from data, and deploy scalable systems tailored to your domain — from day one.
Discover ServicesAI-Powered Solutions We Delivered
Trusted by Industry Leaders:
Blackthorn AI is a leading expert in AI software development, delivering innovative solutions tailored to meet diverse business needs.
Read more0+
Projects delivered
0+
Peer-reviewed publication
0+
PhD-Level Experts
0+
Years of full-cycle development experience
Blackthorn AI’s team combines deep technical expertise with a thorough understanding of industry challenges, offering bespoke AI solutions that empower businesses to innovate and excel in a competitive market.
Alex Gurbych, PhD
Chief Executive Officer (CEO)
Natalya Shakhovska, DrSci, Prof.
Chief Scientific Officer (CSO)
Dmytro Krasnienkov, PhD
Principal Scientist, Bioinformatics
Serhiy Protsenko, DrSci, Prof.
Principal Data Scientist
Delve into our latest research and publications demonstrating our commitment to AI and software development excellence
All Publications
HbA1c and leukocyte mtDNA levels as major factors associated with post-COVID-19 syndrome in type 2 diabetes patients
Ensembling machine learning models to boost molecular affinity prediction
Filling the Gap in LogP and pKa Evaluation for Saturated Fluorine-Containing Derivatives With Machine Learning
Enhancing Solar Energy Production Forecasting Using Advanced Machine Learning and Deep Learning Techniques: A Comprehensive Study on the Impact of Meteorological Data
What Clients Say About
Our Impact
Clients consistently praise our high accuracy in AI models, with projects achieving up to 84% precision and outperforming open-source models by 18%
Thanks to their open management style, they had an exceptional partnership that resulted in success.
Serhii Ivanets
CTO, VAN GroupThey always delivered on time and showed 100% transparency in the project development.
Alejandro Gonzalez
Product manager, Monitoring LifeAlex and his team work fast and provide quality work because they pay attention to detail.
Jason Mitakidis
Founder at HealthWorks Dx Inc.They were highly skilled in both development and scientific application needs in discovery.
Diana Kraskouskaya
CEO, Dalriada Drug DiscoveryThanks to their open management style, they had an exceptional partnership that resulted in success.
Serhii Ivanets
CTO, VAN GroupThey always delivered on time and showed 100% transparency in the project development.
Alejandro Gonzalez
Product manager, Monitoring LifeAlex and his team work fast and provide quality work because they pay attention to detail.
Jason Mitakidis
Founder at HealthWorks Dx Inc.They were highly skilled in both development and scientific application needs in discovery.
Diana Kraskouskaya
CEO, Dalriada Drug Discovery#1 in Top 100 AI Companies Clutch, 2024
Top Artificial Intelligence Company
Clutch, 2024
Cloud Engineer
Google Cloud Certified Professional
Data Engineer
Google Cloud Certified Professional
Cloud Architect
Google Cloud Certified Professional
Top Global AI Company
Clutch, 2023
Solutions Architect
AWS Certified Associate
#1 in Top 100 AI Companies
The Manifest, 2023
Data Engineer
Google Cloud Certified Professional
Top Machine Learning AI Company
Clutch, 2023
TensorFlow
Developer Certificate
5.0 Overall Review Rating
Clutch, 2022
Oracle Certified
Java SE 8 Programmer AssociateStraight to Business?
Blackthorn AI empowers organisations to solve complex, cross-industry challenges with intelligent, scalable solutions
Book a MeetingFrom industry-leading conferences to in-house innovation days, here’s a look at the events that have shaped our journey.
All Events
How can AI accelerate drug discovery for biotech startups?
+AI can reduce early-stage drug discovery costs by up to 80% through predictive modeling, automated screening, and molecular simulation. At Blackthorn.ai, we develop custom AI pipelines that analyze complex biological data, identify promising compounds, and shorten the R&D cycle from years to months – helping biotech startups reach proof-of-concept faster and attract investor confidence.
How do you ensure data security and regulatory compliance?
+Data protection in biotech is non-negotiable. We follow industry-grade standards like ISO 27001, HIPAA, and GDPR, implementing encrypted pipelines, controlled access layers, and secure on-premise or hybrid deployments. This ensures that sensitive genomic, clinical, and research data remains fully protected throughout development.
Can AI help us manage and analyze multi-omics data?
+Absolutely. We build AI-powered multi-omics platforms that unify genomics, proteomics, and metabolomics datasets into one scalable environment. Our tools automate preprocessing, quality control, and cross-omics correlation – allowing scientists to focus on discovery instead of data wrangling.
We’re a small biotech startup – is AI development realistic for us?
+Yes – and it’s often the smartest move you can make early on. We offer a 90-Day AI Discovery Sprint, where we build your first MVP (AI model or platform prototype) fast and cost-efficiently. This approach helps startups demonstrate technical feasibility to investors and gain early market traction without committing to a full-scale development yet.
How do you measure success in biotech AI projects?
+We define clear KPIs from day one: prediction precision, experiment optimization rate, cost reduction, and time-to-result. Each milestone is benchmarked to measurable ROI, ensuring transparency and progress tracking throughout the project.